Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dan Lemaitre Insider Profile
4 Followers
Dan Lemaitre, Director at Endologix, holds 10.80K shares in Globus Medical (Ticker: GMED), holds 0.00 shares in Endologix (Ticker: ELGXQ). Most recently, Dan Lemaitre Sold ― shares of Globus Medical on May 17, 2023 for an estimated value of 2.48M.
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
-2.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Dan Lemaitre holds in companies
Most Profitable Insider Trade
Stock:
Endologix
(ELGXQ)
(ELGXQ)
Rating:Informative Buy
Date:May 23, 2017 - May 23, 2018
Return:+11.20%
The most profitable trade made by Dan Lemaitre
Dan Lemaitre's Trading History
Endologix
Sep 17, 2020
―
Informative Sell
2.59K
$0.00
Globus Medical
May 17, 2023
Director
Informative Sell
2.48M
$544.64K
List of latest transactions for each holding click on a transaction to see Dan Lemaitre's performance on stock
You May Also Like
Dan Lemaitre insider profile FAQ
What is the percentage of profitable transactions made by Dan Lemaitre?
The percentage of profitable transactions made by Dan Lemaitre is 40%.
What is the average return per transaction made by Dan Lemaitre?
The average return per transaction made by Dan Lemaitre is -2.90%.
What stocks does Dan Lemaitre hold?
Dan Lemaitre holds: ELGXQ, GMED stocks.
What was Dan Lemaitre’s latest transaction?
Dan Lemaitre latest transaction was an Informative Sell of $2.48M.
What was Dan Lemaitre's most profitable transaction?
Dan Lemaitre’s most profitable transaction was an Informative Buy of ELGXQ stock on May 23, 2017. The return on the trade was 11.20%.
What is Dan Lemaitre's role in Endologix?
Dan Lemaitre's role in Endologix is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.